Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19

PURPOSE: Limited data are available on venovenous extracorporeal membrane oxygenation (ECMO) in patients with severe hypoxemic respiratory failure from coronavirus disease 2019 (COVID-19). METHODS: We examined the clinical features and outcomes of 190 patients treated with ECMO within 14 days of ICU...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaefi, Shahzad, Brenner, Samantha K., Gupta, Shruti, O’Gara, Brian P., Krajewski, Megan L., Charytan, David M., Chaudhry, Sobaata, Mirza, Sara H., Peev, Vasil, Anderson, Mark, Bansal, Anip, Hayek, Salim S., Srivastava, Anand, Mathews, Kusum S., Johns, Tanya S., Leonberg-Yoo, Amanda, Green, Adam, Arunthamakun, Justin, Wille, Keith M., Shaukat, Tanveer, Singh, Harkarandeep, Admon, Andrew J., Semler, Matthew W., Hernán, Miguel A., Mueller, Ariel L., Wang, Wei, Leaf, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851810/
https://www.ncbi.nlm.nih.gov/pubmed/33528595
http://dx.doi.org/10.1007/s00134-020-06331-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851810/
https://www.ncbi.nlm.nih.gov/pubmed/33528595
http://dx.doi.org/10.1007/s00134-020-06331-9

Ejemplares similares